Diabetes and CKD: Strategies for Diagnosis and Treatment
May 21, 2024 - 00:11:00
Radio and PodcastLive Radio & PodcastsScience & Medicine
Discussing a T2D Medication That Could Reduce Insulin Needs in T1D
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: David Selzer, MD New research suggests that a GLP-1 receptor agonist medication, semaglutide, which has been approved for type 2 diabetes and obesity, could al...
About This Episode
Discussing a T2D Medication That Could Reduce Insulin Needs in T1D is an episode from Diabetes Discourse by ReachMD. Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: David Selzer, MD New research suggests that a GLP-1 receptor a...
Podcast
This episode belongs to Diabetes Discourse.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Nov 27, 2023, 00:11:30 long, audio available.
Related Episodes
Continue listening to more episodes from Diabetes Discourse.
Uncovering the Prevalence of Type 1 Diabetes in Older Adults
May 9, 2024 - 00:07:30
Concentrating on the MOMPOD Trial for Metformin Plus Insulin
Apr 12, 2024 - 00:10:30
Utilizing Hybrid Closed-Loop Technology for T1D Pediatric Patients
Apr 9, 2024 - 00:07:00
Semaglutide Reduces CV Events in Non-Diabetic, Overweight Patients
Apr 8, 2024 - 00:11:30
Overcoming Obesity: Insights from the SURMOUNT-4 Trial
Mar 27, 2024 - 00:12:30
Strategies for Addressing Diabetes Stigma and Discrimination
Feb 1, 2024 - 00:11:00
How the Artificial Pancreas Can Help Diabetic Patients
Dec 20, 2023 - 00:03:00
Questions About This Episode
What is Discussing a T2D Medication That Could Reduce Insulin Needs in T1D about?
Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: David Selzer, MD New research suggests that a GLP-1 receptor agonist medication, semaglutide, which has been approved for type 2 diabetes and obesity, could also be used to treat type 1 diabetes in patients. So what are the risks for patients who have type 1 diabetes and who are obese? Joining Dr. Mary Katherine Cheeley to discuss this is Dr. David Selzer, Clinical Instructor of Medicine at NYU Grossman School of Medicine and leads the Medical Weight Loss Program at NYU Langone Medical Associates in the Florida Division.
Where can I listen to Discussing a T2D Medication That Could Reduce Insulin Needs in T1D?
You can listen to Discussing a T2D Medication That Could Reduce Insulin Needs in T1D online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Discussing a T2D Medication That Could Reduce Insulin Needs in T1D from?
Discussing a T2D Medication That Could Reduce Insulin Needs in T1D is an episode from Diabetes Discourse by ReachMD.
How long is this episode?
This episode is 00:11:30 long.
When was this episode published?
This episode was published on Nov 27, 2023.
Can I save Discussing a T2D Medication That Could Reduce Insulin Needs in T1D for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from Diabetes Discourse?
Yes. This page shows related episodes from Diabetes Discourse when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Discussing a T2D Medication That Could Reduce Insulin Needs in T1D?
You can listen to Discussing a T2D Medication That Could Reduce Insulin Needs in T1D on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Discussing a T2D Medication That Could Reduce Insulin Needs in T1D is from Diabetes Discourse by ReachMD.
What are the episode details?
Published Nov 27, 2023 and 00:11:30 long